This memorandum reiterates and clarifies procedures for investigating deaths of possible violation of protections afforded enemy prisoners of war, retained personal, civilian internees, and other detainees.

Treatment of Reserve Component Members with Delayed-Effective Date Active Duty Orders in Military Treatment Facilities

Policy for Stipend/Annual Grant Increase for the Armed Forces Health Professions Scholarship/Financial Assistance Program

Policy Guidance for Referral Management

All personnel with actual or potential exposures to DU will be identified, assessed, treated (if needed), and assigned a potential exposure level (I, II, or Ill).

This memo directs the Services to report their DU urine bioassay results

This policy memorandum establishes policy and provides program guidance for Medical Management (MM) programs within the Direct Care System (DCS) of the Military Health System (MHS).

All Services shall modify their Human Immunodeficiency Virus (HIV-1) testing program to provide a maximum two-year interval between routine tests for active duty personnel.

Policy on Reserve Transitional Assistance Management Program

Military Health System Information Assurance Policy Guidance

This memo establishes DOD policy on status reporting procedures for anthrax and smallpox vaccinations.

The Department has developed criteria for the approval of bioassays to support deployment operations (Attachment 2). Bioassays for Depleted Uranium and lead (Attachments 3 and 4) are approved for use at this time to assess human exposures during or after deployment and combat operations.

The policy memorandum establishes the plan to improve obstetrical services in military treatment facilities through the implementation of family-centered care before, during and after childbirth.